Novel self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of cinnarizine: Design, optimization, and in-vitro assessment

AAPS PharmSciTech

Volumn 13, Issue 3, 2012, Pages 967-977

  Shahba, Ahmad Abdul Wahhab ^a   Mohsin, Kazi ^a   Alanazi, Fars Kaed ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

cinnarizine; lipid based formulations; oral drug delivery; SNEDDS; solubility enhancement

Indexed keywords

ACYLGLYCEROL; CINNARIZINE; DRUG SOLVENT; SURFACTANT;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DILUTION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG MARKETING; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; IN VITRO STUDY; LIPOPHILICITY; NANOEMULSION; PRECIPITATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SELF NANOEMULSIFYING DRUG DELIVERY SYSTEM; TABLET;

ADMINISTRATION, ORAL; CINNARIZINE; DRUG DELIVERY SYSTEMS; DRUG DESIGN; EMULSIONS; NANOPARTICLES;

EID: 84866104465     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9821-4     Document Type: Article

References (25)

1. Date AA, Desai N, Dixit R, Nagarsenker M. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (Lond). 2010;5:1595-616.
2. Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329:166-72.
3. Lei Y, Lu Y, Qi J, Nie S, Hu F, Pan W, et al. Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility. Int J Nanomedicine. 2011;6:795-805.
4. Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm. 2001;212:233-46.
5. Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci. 2000;11:S93-8.
6. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173-82.
7. Charman SA, Charman WN, Rogge MC, Wilson TD, Dutko FJ, Pouton CW. Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound. Pharm Res. 1992;9:87-93.
8. Charman WN, Rogge MC, Boddy AW, Berger BM. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J Clin Pharmacol. 1993;33:381-6.
9. Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29:278-87.
10. Mohsin K, Long MA, Pouton CW. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci. 2009;98:3582-95.
11. Loftsson T, Hreinsdóttir D, Másson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm. 2005;302:18-28.
12. Kossena GA, Charman WN, Boyd BJ, Dunstan DE, Porter CJ. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. J Pharm Sci. 2004;93:332-48.
13. Gu CH, Rao D, Gandhi RB, Hilden J, Raghavan K. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. J Pharm Sci. 2005;94:199-208.
14. Ogata H, Aoyagi N, Kaniwa N. Gastric acidity dependent bioavailability of cinnarizine from two commercial capsules in healthy volunteers. Int J Pharm. 1986;29:113-20.
15. B-q L, G-q Y, S-h F, Gao J-y, Gu F-m, Dong X, et al. Effect of route of administration on the pharmacokinetics and toxicokinetics of cinnarizine in dogs. Eur J Pharm Sci. 2010;40:197-201.
16. Shi S, Chen H, Cui Y, Tang X. Formulation, stability and degradation kinetics of intravenous cinnarizine lipid emulsion. Int J Pharm. 2009;373:147-55.
17. Baka E, Comer JEA, Takács-Novák K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharmaceut Biomed. 2008;46:335-41.
18. Atef E, Belmonte AA. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). Eur J Pharm Sci. 2008;35:257-63.
19. Shahba AA, Mohsin K, Alanazi FK. The studies of phase equilibria and efficiency assessment for self-emulsifying lipid based formulations. AAPS PharmSciTech. 2012;13:522-33. doi: 10.1208/s12249-012-9773-8.
20. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. AAPS PharmSciTech. 2005;6:E372-90.
21. FDA. Guidance for industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Rockville, 1997.
22. Abdel-Hamid M, Shahba A, Mohsin K, Alanazi F. Ultra performance liquid chromatography assay for cinnarizine in lipid-based formulations. Asian J Chem. 2012;24:595-600.
23. Tokumura T, Tsushima Y, Tatsuishi K, Kayano M, Machida Y, Nagai T. Enhancement of the oral bioavailability of cinnarizine in oleic acid in beagle dogs. J Pharm Sci. 1987;76:286-8.
24. Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60:625-37.
25. Alayoubi A, Satyanarayanajois SD, Sylvester PW, Nazzal S. Molecular modelling and multisimplex optimization of tocotrienol-rich self emulsified drug delivery systems. Int J Pharm. 2012;426:153-61.